Enchasing Polyp Detection: The Effect of Adding Polyp Detection Attachment Device to Computer Aid Detection System.

NCT ID: NCT06116864

Last Updated: 2023-11-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

1766 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-10-23

Study Completion Date

2025-04-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Despite the widespread use of colonoscopy, the ongoing challenge of potentially missing polyps remains. Previous studies have independently shown that both Endocuff, a colonoscope attachment device for polyp detection, and Computer-Aided Detection (CADe) systems have individually demonstrated enhanced lesion detection and safety. This study seeks to evaluate the efficacy of combining the Endocuff CADe versus using CADe alone in colonoscopy procedures for colorectal cancer screening and surveillance. This research project aims to ascertain whether the synergistic application of these technologies yields superior outcomes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colon Cancer Screening Colon Cancer Surveillance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

This is a randomized controlled trial that compares Endocuff with Gi Genius (group A) to GI Genius alone (group B) for patients who are undergoing elective outpatient colonoscopy. Patients will be randomized by a secure online randomization software that will allocate patients in a 1:1 ratio to group A or group B.
Primary Study Purpose

SCREENING

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Endocuff + GI Genius

Endocuff is a polyp-detecting colonoscope attachment device. GI Genius is and Computer-Aid Detection (CADe) system to detect polyps

Group Type EXPERIMENTAL

Endocuff and GI Genius

Intervention Type DEVICE

Endocuff is a polyp-detecting colonoscope attachment device. GI Genius is and Computer-Aid Detection (CADe) system to detect polyps

GI Genius

GI Genius is and Computer-Aid Detection (CADe) system to detect polyps

Group Type ACTIVE_COMPARATOR

GI Genius

Intervention Type DEVICE

GI Genius is and Computer-Aid Detection (CADe) system to detect polyps

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Endocuff and GI Genius

Endocuff is a polyp-detecting colonoscope attachment device. GI Genius is and Computer-Aid Detection (CADe) system to detect polyps

Intervention Type DEVICE

GI Genius

GI Genius is and Computer-Aid Detection (CADe) system to detect polyps

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \> 18
* Patients scheduled for an outpatient screening or surveillance colonoscopy.

Exclusion Criteria

* Patients who require diagnostic colonoscopy (e.g.; anemia or GI bleeding).
* Patients requiring deep ileal intubation.
* Patients with inflammatory bowel disease.
* Patients with radiotherapy-induced colitis or other severe colitis.
* Patients with colonic strictures.
* Patients with acute diverticulitis.
* Patients with large bowel obstruction.
* Patients scheduled for therapeutic colonoscopy (e.g., planned endoscopic mucosal resection for known polyps).
* Patients scheduled for assessment of a known colonic lesion.
* Patients with a known history of hereditary polyposis syndrome or untreated colon cancer.
* Patients with a history of colon resection.
* Patients on continuous anti-thrombotic therapy
* Pregnancy.
* Patients who are ineligible for colonoscopy due to medical or psychiatric conditions.
* Patients who are vulnerable or unable to consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Marshall University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Wesam Frandah

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Wesam Frandah, MD

Role: PRINCIPAL_INVESTIGATOR

Marshall University Joan C. Edwards School of Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Marshall University Joan C. Edwards School of Medicine/Cabell Huntington Hospital

Huntington, West Virginia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2094805

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.